EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Biotech Stocks To Keep An Eye On - October 6th - Markets Daily
AI Breakthrough: Room Temperature Storage for mRNA Vaccines, ETPharma
U.S. Market Brief: Wall Street Ends Lower as Fed Minutes Reinforce Rate Rise Outlook
U.S. Market Brief: Stocks Slip as Fed Minutes Signal Another Rate Hike
Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets
Odd Biotech Action Is Creating Opportunities for Deal Hunters
Morgan Stanley Issues Positive Forecast for Moderna (NASDAQ:MRNA) Stock Price
Moderna (NASDAQ:MRNA) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Stock Observer
Top Healthcare Stocks To Watch Now - October 7th - Daily Political
Moderna (MRNA) Could Be 57% Above Fair Value On New COO Appointment
Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?
Moderna (NASDAQ:MRNA) Hits New 52-Week High - Time to Buy?
Paramount-Warner Bros. deal finally closes: Stocks to watch on Tuesday
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher
Promising Healthcare Stocks To Watch Now - October 6th - Stock Observer
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
NVAX Stock Outruns Moderna As Vaxcyte's Shot Clears A Late-Stage Test
MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns
Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up
Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips
Value Stocks To Consider - October 5th - Stock Observer
ETFs Are Net Sellers of Moderna (MRNA) on Thursday
Hawaii pharmacies offering COVID vaccines amid uptick
Moderna (MRNA) Soars 175% in Q3: Can The Stock Keep Running?
Jim Cramer Says This Stock Could Rise Like Moderna (MRNA)
Biotech Stocks To Watch Now - October 2nd - Daily Political
Why Is Moderna (MRNA) Bringing Back A Manufacturing Leader As First COO?
Biotech Stocks To Watch Now - October 2nd - Zolmax
S&P500: Futures Rise as Oil Retreats Before Payrolls | FXEmpire
Moderna (MRNA) Jumps 2.2% in Premarket as Nasdaq-100 Entry Confirmed for October 9
Moderna To Join Nasdaq-100, Replacing Warner Bros. Discovery
Micron Says Memory Supply Will Be Much Tighter in 2028. Sandisk's Contracts Limit How Much It Can Gain.
Northwestern Wins Bid to Strike Moderna Government Sales Defense
September's Leaders and Laggards
Moderna loses US government license defense in patent case
Why Citi Is Sounding the Alarm on Moderna Stock
Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water
Biotech Stocks To Watch Now - October 1st - Daily Political
Lyme Disease Market: Steady Growth Ahead as Vaccine Candidates and Novel Preventive Therapies Advance Through 2034 | ABNewswire
This Analyst Just Downgraded Moderna Stock. Here's Why.
Moderna Stock Slumps as Citi Says It's Time to Sell After 500% Rally This Year
Moderna Stock Falls 7% After Adding Chief Operating Officer Role
Moderna (NASDAQ:MRNA) Shares Gap Down - Here's Why
Moderna Names Juan Andres As Chief Operating Officer
Case: Patents/Eligibility (D. Del.)
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat
Target upgraded, Moderna downgraded: Wall Street's top analyst calls
Citi Downgrades Moderna (MRNA) Stock to Sell After 222% Rally
Here Are Wednesday's Top Wall Street Analyst Research Calls: Ally Financial, BankUnited, Ciena Corporation, CoreWeave, Dow, FormFactor, Lumentum Holdings, Moderna, Target, and More
Premarket movers: Micron; Boeing rises, Moderna slides
Moderna (NASDAQ:MRNA) Shares Gap Down - Should You Sell? - Stock Observer
Citi tells investors it's time to sell Moderna after 600%-plus stock gains | Morningstar
MRNA: Cancer Vaccine Wins Matter, But The Case Now Rests On Narrower Proof Points
Moderna has been on a tear since mid-August. Citi now sees it plunging 60%
Bayer Advances Patent Suit Over Moderna, Pfizer Covid Vaccines
Moderna (NASDAQ:MRNA) Sets New 12-Month High - Here's What Happened
Promising Healthcare Stocks To Follow Today - September 29th - Stock Observer
Healthcare Stocks To Add to Your Watchlist - September 28th - Zolmax
MIT engineers use artificial intelligence to create heat-resistant RNA vaccines
Top Biotech Stocks To Research - September 28th - Daily Political
Why Did AMD, HPE, MRNA Stocks Surge To 52-Week Highs Last Week?
Biotech Stocks To Follow Today - September 27th - Daily Political
Moderna (MRNA) Held Investment Talks With The UAE Government
Top Biotech Stocks To Add to Your Watchlist - September 26th - Zolmax
Weekly Market Update: Stocks Gain 1.09% as Technology Rises, Energy Falls | Morningstar
Stock Traders Purchase Large Volume of Call Options on Moderna (NASDAQ:MRNA)
Moderna (MRNA) Stock Looks Overvalued Against Its Current Sales Base
Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of "Hold" from Analysts
Moderna Inc. (MRNA) Holds High-Level Investment Talks With UAE, Soars to 4-Year Peak
Healthcare Stocks To Watch Today - September 24th - Zolmax
Bucks Music Group Signs Pianist And Composer Piotr Wiese
Moderna (MRNA) Stock Reaches New 52-Week Peak Amid Cancer Treatment Breakthroughs
Biotech Stocks At 52-Week Highs - TKNO, MRNA, ATRC, ILMN
Nykredit A S Acquires New Holdings in Moderna, Inc. $MRNA
Engineers Gate Manager LP Cuts Holdings in Moderna, Inc. $MRNA
Healthcare Stocks Fall - Healthcare Roundup | Morningstar
Moderna Eyes Cancer Vaccine Filing as It Expands Beyond COVID
Healthcare Stocks To Add to Your Watchlist - September 23rd - Stock Observer
Biotech Stocks To Follow Now - September 23rd - Stock Observer
Moderna (MRNA) Tied To AI Drug Push As Bob Langer Takes New Advisory Role
Moderna (MRNA) Stock Looks Very Expensive As Shares Surge Over 1 Year
Moderna (NASDAQ:MRNA) Trading Up 5.6% - What's Next?
Top Value Stocks To Watch Today - September 22nd - Zolmax
Moderna (NASDAQ:MRNA) Trading 5.6% Higher - Time to Buy? - Daily Political
Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up?
mRNA flu vaccine wins FDA approval, promising a faster shot
How the Merck-Moderna mRNA melanoma vaccine is built per patient
Top Healthcare Stocks To Keep An Eye On - September 22nd - Stock Observer
Biotech Stocks To Consider - September 19th - Zolmax
MRNA: Melanoma Success Lifts The Story, The Stock Still Prices In Too Much
Moderna (NASDAQ:MRNA) Trading Up 12.3% - Still a Buy?
Health Care Up on Drug Breakthrough Hopes - Health Care Roundup | Morningstar
AMD, Intel, Meta, Warner Bros., Moderna, Grail, Strategy, and More Stocks That Explain Today's Market
Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters. | Morningstar
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
